Approvals/TGA/BRINTELLIX vortioxetine (as hydrobromide) 15 mg film-coated tablet blister pack

Approved

STANDARD

BRINTELLIX vortioxetine (as hydrobromide) 15 mg film-coated tablet blister pack

Lundbeck Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 3a524ad616ffa2b4
Product Name: BRINTELLIX vortioxetine (as hydrobromide) 15 mg film-coated tablet blister pack
Artg Id: 203981
Artg Name: BRINTELLIX vortioxetine (as hydrobromide) 15 mg film-coated tablet blister pack
Sponsor: Lundbeck Australia Pty Ltd
Company Detail Path: /organization/lundbeck-australia-pty-ltd
Artg Date: 2014-03-31
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/0b56b651df306a60520613e2e7c94c17.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/03bee635964f65dd84cdeae1839ea3df.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

3a524ad616ffa2b4

Type

Standard